El GLP-1 reduce el apetito y la ingesta de alimentos al actuar sobre los centros de saciedad en el cerebro, lo que conduce a una disminucin en la ingesta y ayuda a la prdida de peso
This trial let us know that tirzepatide had the capacity to help patients without diabetes lose an average of about 20% of their body weight when taking the 15 mg dose
One randomized, double-blind, placebo-controlled trial found no evidence that a daily antioxidant supplement containing 12 mg of -carotene, 500 mg of vitamin C, and 400 mg of vitamin E, when taken for up to 12 months, improved mental performance in elderly people (163)
Semaglutide is a GLP-1 receptor agonist that can be used for diabetics, but is also approved for weight loss
Obesity is a chronic, pervasive health concern, and there is no single therapy that works for every patient, he explained